骨外結石化が経口中性リン酸療法を複雑化する.

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C.

Hepatology (Baltimore, Md.)·1999

Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis.

Annals of internal medicine·1997

Efficacy and tolerance of a 6-month treatment course of daily interferon-alpha 2a for chronic hepatitis C with cirrhosis. The Australian Hepatitis C Study Group.

Journal of viral hepatitis·1997

Management of haematemesis and melaena.

The Medical journal of Australia·1997

Treatment of cirrhotic hepatitis C virus patients with daily doses of interferon-alpha 2a.

Journal of viral hepatitis·1997

Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre.

Journal of hepatology·1996

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

mSiO2@Chitosan-derived carbon hybrid for efficient removal of cationic dyes from aqueous solutions: kinetic, isotherm, and thermodynamic studies.

RSC advances·2026

Cloud condensation experiments probe nanoscale effects on water vapor adsorption by insoluble particles.

Communications chemistry·2026

Assessment of silver nanoparticle mediated changes in osmotic fragility of red blood cells by a LASER diode based photoacoustic system.

The Journal of the Acoustical Society of America·2026

Hydrodynamic dispersion drives viral-cellular contact for gene delivery in porous media.

Proceedings of the National Academy of Sciences of the United States of America·2026

Interplay between capillary and dispersion forces in adhesion under ambient conditions.

The Journal of chemical physics·2026

Changes in Corneal Epithelial Barrier Function and Zonula Occludens-1 Distribution with Concomitant Use of Silver Nitrate and Latanoprost in Rabbits.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics·2026

関連する実験動画

骨外結石化が経口中性リン酸療法を複雑化する

関連する概念動画

A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C.

Effect of fluoroquinolone on the enhanced nitric oxide-induced peripheral vasodilation seen in cirrhosis.

Efficacy and tolerance of a 6-month treatment course of daily interferon-alpha 2a for chronic hepatitis C with cirrhosis. The Australian Hepatitis C Study Group.

Management of haematemesis and melaena.

Treatment of cirrhotic hepatitis C virus patients with daily doses of interferon-alpha 2a.

Chronic hepatitis C: effect of alcohol on hepatitic activity and viral titre.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

mSiO2@Chitosan-derived carbon hybrid for efficient removal of cationic dyes from aqueous solutions: kinetic, isotherm, and thermodynamic studies.

Cloud condensation experiments probe nanoscale effects on water vapor adsorption by insoluble particles.

Assessment of silver nanoparticle mediated changes in osmotic fragility of red blood cells by a LASER diode based photoacoustic system.

Hydrodynamic dispersion drives viral-cellular contact for gene delivery in porous media.

Interplay between capillary and dispersion forces in adhesion under ambient conditions.

Changes in Corneal Epithelial Barrier Function and Zonula Occludens-1 Distribution with Concomitant Use of Silver Nitrate and Latanoprost in Rabbits.

関連する実験動画

骨外結石化が経口中性リン酸療法を複雑化する

関連する概念動画

関連記事